144 related articles for article (PubMed ID: 8370476)
1. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis.
Häyry P; Räisänen A; Ustinov J; Mennander A; Paavonen T
FASEB J; 1993 Aug; 7(11):1055-60. PubMed ID: 8370476
[TBL] [Abstract][Full Text] [Related]
2. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis.
Mennander A; Räisänen A; Paavonen T; Häyry P
Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036
[TBL] [Abstract][Full Text] [Related]
3. Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection.
Räisänen-Sokolowski A; Mennander A; Ustinov J; Paavonen T; Häyry P
Transplant Proc; 1993 Feb; 25(1 Pt 2):944-5. PubMed ID: 8095115
[No Abstract] [Full Text] [Related]
4. Blockade of growth factor synthesis and growth factor action: two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury.
Häyry P; Aavik E; Myllärniemi M
Metabolism; 1996 Aug; 45(8 Suppl 1):101-3. PubMed ID: 8769397
[TBL] [Abstract][Full Text] [Related]
5. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.
Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ
Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687
[TBL] [Abstract][Full Text] [Related]
7. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.
Lemström KB; Aho PT; Bruggeman CA; Häyry PJ
Arterioscler Thromb; 1994 Dec; 14(12):2043-52. PubMed ID: 7981194
[TBL] [Abstract][Full Text] [Related]
9. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection.
Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J
Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433
[No Abstract] [Full Text] [Related]
10. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
[TBL] [Abstract][Full Text] [Related]
11. Towards understanding the pathophysiology of chronic rejection.
Häyry P; Mennander A; Yilmaz S; Ustinov J; Räisänen A; Miettinen A; Lautenschlager I; Lemström K; Bruggeman CA; Paavonen T
Clin Investig; 1992 Sep; 70(9):780-90. PubMed ID: 1450632
[TBL] [Abstract][Full Text] [Related]
12. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.
Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T; Häyry P
Arterioscler Thromb; 1991; 11(3):671-80. PubMed ID: 2029505
[TBL] [Abstract][Full Text] [Related]
13. Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis.
Murata S; Sundell CL; Lijkwan MA; Balsam LB; Hammainen P; Coleman C; York C; Luchoomun J; Suen KL; Howard R; Somers PK; Morris RE; Robbins RC
Transplantation; 2004 May; 77(10):1494-500. PubMed ID: 15239610
[TBL] [Abstract][Full Text] [Related]
14. Specific effects of estrogen on growth factor and major histocompatibility complex class II antigen expression in rat aortic allograft.
Saito S; Motomura N; Lou H; Ramwell PW; Foegh ML
J Thorac Cardiovasc Surg; 1997 Nov; 114(5):803-9; discussion 809-10. PubMed ID: 9375610
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants.
Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124
[No Abstract] [Full Text] [Related]
16. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
Räisänen-Sokolowski A; Myllärniemi M; Häyry P
Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
[No Abstract] [Full Text] [Related]
17. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated.
Mennander A; Paavonen T; Häyry P
Arterioscler Thromb; 1993 Jul; 13(7):1019-25. PubMed ID: 8318503
[TBL] [Abstract][Full Text] [Related]
18. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts.
Räisänen-Sokolowski AK; Pakkala IS; Samila SP; Binderup L; Häyry PJ; Pakkala ST
Transplantation; 1997 Apr; 63(7):936-41. PubMed ID: 9112343
[TBL] [Abstract][Full Text] [Related]
19. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
[TBL] [Abstract][Full Text] [Related]
20. Hyperlipidemia accelerates allograft arteriosclerosis (chronic rejection) in the rat.
Räisänen-Sokolowski A; Tilly-Kiesi M; Ustinov J; Mennander A; Paavonen T; Tikkanen MJ; Häyry P
Arterioscler Thromb; 1994 Dec; 14(12):2032-42. PubMed ID: 7981193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
